JNJ-16269110 (R256918)

JNJ-16269110 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-16269110 (R256918), covering 2014-05-13 to 2014-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients [Phase 2]